Nuevolution A/S is a unique drug discovery company poised to revolutionize drug discovery by utilising its proprietary Chemetics® technology to efficiently synthesize and identify drug leads by the screening of multi-million member libraries to therapeutically relevant targets.
Chemetics® represents the ultimate convergent drug discovery technology. It is a unique, patent protected hybrid of proven wet chemistry and molecular biology that enables the rapid synthesis and selection of drug-like lead compounds among millions to billions of small molecule compounds in a single test tube.
Learn more about our company and intriguing technology at www.nuevolution.com.
Visit my LinkedIn profile.
Home
